Literature DB >> 6252241

Solid-phase enzyme immunoassay for determination of antibodies to cytomegalovirus.

R V Krishna, O H Meurman, T Ziegler, U H Krech.   

Abstract

A solid-phase enzyme immunoassay for the determination of immunoglobulin H (IgG) and IgM antibodies to cytomegalovirus is described. The enzyme immunoassay gave reliable and consistent results which were in concordance with those obtained by the complement fixation test and the indirect immunofluorescence test. Antibodies to herpes simplex and varicella-zoster viruses did not interfere in the enzyme immunoassay for cytomegalovirus IgM antibodies. In a few patients with IgM antibodies to Epstein-Barr virus, cytomegalovirus IgM antibodies were also detected. False-positive cytomegalovirus IgM antibody results were observed in sera containing both the rheumatoid factor and cytomegalovirus IgG antibodies. This rheumatoid factor interference was overcome by the absorption of sera with polymerized human gamma globulin. The absorption did not affect true cytomegalovirus IgM antibody titers. Also described is a simple enzyme immunoassay that makes possible a more sensitive detection of the rheumatoid factor than the latex agglutination test.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6252241      PMCID: PMC273518          DOI: 10.1128/jcm.12.1.46-51.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-IgM.

Authors:  P V Shirodaria; K B Fraser; F Stanford
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

2.  Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence.

Authors:  H Schmitz; R Haas
Journal:  Arch Gesamte Virusforsch       Date:  1972

3.  A study of complement-fixing, immunofluorescent, and neutralizing antibodies in human cytomegalovirus infections.

Authors:  U Krech; M Jung; W Sonnabend
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1971-06

4.  Demonstration of IgM cytomegalovirus-antibodies as an aid to early diagnosis in adults.

Authors:  M M Langenhuysen; T H The; H O Nieweg; J G Kapsenberg
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

5.  Mixed cryoimmunoglobulinaemia in infectious mononucleois and Cytomegalovirus mononucleosis.

Authors:  O Wager; J A Räsänen; A Hagman; E Klemola
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

6.  Fluorescent-antibody test for cytomegalovirus macroglobulin.

Authors:  J B Hanshaw; H J Steinfeld; C J White
Journal:  N Engl J Med       Date:  1968-09-12       Impact factor: 91.245

7.  Differences in anti-protein A activity among IgG subgroups.

Authors:  G Kronvall; R C Williams
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

8.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.

Authors:  M Fiala; J E Payne; T V Berne; T C Moore; W Henle; J Z Montgomerie; S N Chatterjee; L B Guze
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

9.  Enzyme-immunoassays for antibodies in measles, cytomegalovirus infections and after rubella vaccination.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1976-04

10.  Immunoperoxidase technique for detection of antibodies to human cytomegalovirus.

Authors:  G Gerna; C J McCloud; R W Chambers
Journal:  J Clin Microbiol       Date:  1976-03       Impact factor: 5.948

View more
  10 in total

1.  Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

Authors:  J Lycke; B Svennerholm; E Hjelmquist; L Frisén; G Badr; M Andersson; A Vahlne; O Andersen
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 2.  Immunoserology of infectious diseases.

Authors:  K James
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

3.  Specific and non-specific serological markers in the screening for congenital CMV infection.

Authors:  A el-Mekki; L V Deverajan; S Soufi; O Strannegard; W al-Nakib
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

4.  Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay.

Authors:  J M Middeldorp; J Jongsma; A ter Haar; J Schirm; T H The
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

5.  Efficacy of enzyme-linked immunosorbent assay in serodiagnosis of aspergillosis.

Authors:  S K Mishra; S Falkenberg; K N Masihi
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

6.  Detection of virus-specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection by enzymeimmuno and radioimmunoassay techniques.

Authors:  I Sarov; E Levy; M Aymard; Y Chardonnet; S Bosshard; J P Revillard; M Friedman; E Nord; M Greiff; H Haikin
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

7.  Normalized enzyme-linked immunosorbent assay for determining immunoglobulin G antibodies to cytomegalovirus.

Authors:  D J Kiefer; D A Phelps; S P Halbert
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

8.  Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T M Bakir; H Stern; H Kangro; P D Griffiths; R B Heath
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

9.  Diagnosis of acute toxoplasmosis by an enzyme immunoassay for specific immunoglobulin m antibodies.

Authors:  F Wielaard; H van Gruijthuijsen; W Duermeyer; A W Joss; L Skinner; H Williams; E H van Elven
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

Review 10.  Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Authors:  Maria Grazia Revello; Giuseppe Gerna
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.